NDC Package 43602-399-30 Potassium Citrate

View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

43602-399-30

Package Description:

30 TABLET, EXTENDED RELEASE in 1 BOTTLE

Product Code:

43602-399

Proprietary Name:

Potassium Citrate

Usage Information:

Potassium citrate extended-release tablets are contraindicated:In patients with hyperkalemia (or who have conditions pre-disposing them to hyperkalemia), as a further rise in serum potassium concentration may produce cardiac arrest. Such conditions include: chronic renal failure, uncontrolled diabetes mellitus, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown or the administration of a potassium-sparing agent (such as triamterene, spironolactone or amiloride).In patients in whom there is cause for arrest or delay in tablet passage through the gastrointestinal tract, such as those suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or stricture, or those taking anticholinergic medication.In patients with peptic ulcer disease because of its ulcerogenic potential.In patients with active urinary tract infection (with either urea-splitting or other organisms, in association with either calcium or struvite stones). The ability of Potassium citrate extended-release tablets to increase urinary citrate may be attenuated by bacterial enzymatic degradation of citrate. Moreover, the rise in urinary pH resulting from Potassium citrate therapy might promote further bacterial growth.In patients with renal insufficiency (glomerular filtration rate of less than 0.7 ml/kg/min), because of the danger of soft tissue calcification and increased risk for the development of hyperkalemia.

11-Digit NDC Billing Format:

43602039930

NDC to RxNorm Crosswalk:

RxCUI: 199376 - potassium citrate 5 MEQ Extended Release Oral Tablet
RxCUI: 199376 - K+ citrate 5 MEQ Extended Release Oral Tablet
RxCUI: 199376 - Pot citrate 5 MEQ Extended Release Oral Tablet
RxCUI: 199376 - potassium citrate 540 MG Extended Release Oral Tablet
RxCUI: 199381 - potassium citrate 10 MEQ Extended Release Oral Tablet

Labeler Name:

Ascent Pharmaceuticals Inc

Sample Package:

FDA Application Number:

ANDA214420

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

02-15-2021

End Marketing Date:

02-16-2021

Listing Expiration Date:

02-16-2021

Exclude Flag:

Code Structure:

43602 - Ascent Pharmaceuticals Inc
- 43602-399 - Potassium Citrate
  - 43602-399-30 - 30 TABLET, EXTENDED RELEASE in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
43602-399-05	500 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 43602-399-30?

The NDC Packaged Code 43602-399-30 is assigned to a package of 30 tablet, extended release in 1 bottle of Potassium Citrate, labeled by Ascent Pharmaceuticals Inc. The product's dosage form is and is administered via form.

Is NDC 43602-399 included in the NDC Directory?

No, Potassium Citrate with product code 43602-399 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Ascent Pharmaceuticals Inc on February 15, 2021 and its listing in the NDC Directory is set to expire on February 16, 2021 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 43602-399-30?

The 11-digit format is 43602039930. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	43602-399-30	5-4-2	43602-0399-30

Table of Contents